Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)

China flag China · Delayed Price · Currency is CNY
39.98
+0.89 (2.28%)
At close: May 12, 2026
Market Cap4.33B +142.6%
Revenue (ttm)197.68M +1.8%
Net Income48.60M +4.3%
EPS0.54 +17.8%
Shares Out108.22M
PE Ratio74.67
Forward PEn/a
Dividend0.32 (0.82%)
Ex-Dividend Daten/a
Volume3,184,488
Average Volume3,519,222
Open39.09
Previous Close39.09
Day's Range37.60 - 40.00
52-Week Range17.12 - 42.50
Beta0.57
RSI71.02
Earnings DateApr 25, 2026

About SHA:688163

Shanghai Serum Bio-Technology Co., Ltd. engages in the research, development, production, operation, and sales of antitoxin and antiserum products in China. It offers equine anti-tetanus immunoglobulin, anti-venin, and anti-rabies serum products. The company was founded in 1999 and is based in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 324
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688163
Full Company Profile

Financial Performance

In 2025, SHA:688163's revenue was 196.21 million, an increase of 0.66% compared to the previous year's 194.92 million. Earnings were 51.79 million, an increase of 16.93%.

Financial Statements